About this trial
This study looks at how different antibiotic treatments affect patients in intensive care who have pneumonia caused by the bacteria Stenotrophomonas maltophilia. It compares using one antibiotic versus two antibiotics, and treatment lengths of 7 days versus 14 days, to see which approach helps patients survive better. The study also examines how resistant the bacteria are to antibiotics and how often the pneumonia comes back.
Eligibility criteria
Qualifiers
Adult patients (age ≥ 18 years)
Hospitalized in Medical Intensive Care Unit between January 1, 2018, and December 31, 2023
Intubated and mechanically ventilated
Diagnosed with ventilator-associated pneumonia caused by Stenotrophomonas maltophilia
Disqualifiers
Patients under 18 years old
Patients who refuse the use of their data for research purposes
Trial design
Treatments tested in this trial
- Not listed